Form 4 for QDEL QuidelOrtho Corp
Accepted 2022-06-01 00:00:00 ET · period of report 2022-05-27 · accession 0000899243-22-020478 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-01 | 2022-05-27 | QDEL | Smith Christopher M | Dir | A - Grant | — | +34.6K | 34.6K | New | — |
| D | 2022-06-01 | 2022-05-27 | QDEL | Smith Christopher M | Dir | A - Grant | $0.00 | +208.0K | 208.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-05-27 | A | A | 34,554 | — | 34,554 | D | — | — | (F1) Pursuant to the Business Combination Agreement, dated as of December 22, 2021 (the "Business Combination Agreement") by and among Quidel Corporation, Ortho Clinical Diagnostics Holdings plc ("Ortho"), QuidelOrtho Corporation ("QuidelOrtho"), Orca Holdco, Inc., Laguna Merger Sub, Inc. and Orca Holdco 2, Inc., each ordinary share of Ortho beneficially owned by the Reporting Person at the effective time of the transaction contemplated by the Business Combination Agreement was exchanged for (i) 0.1055 shares of common stock of QuidelOrtho and (ii) $7.14 in cash. (F2) Includes 29,418 restricted stock awards, of which 2,101 shares will vest on July 28, 2022, 8,404 shares will vest on September 9, 2022, 2,100 shares will vest on February 28, 2023 and 8,406 shares will vest on May 27, 2023. |
| 2 | Derivative | Stock Options | 2022-05-27 | A | A | 207,984 | $0.00 | 207,984 | D | $119.06 · — to 2029-12-20 | 207,984 Common Stock | (F4) Vested in full. |